IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v16y2018i4d10.1007_s40258-018-0393-7.html
   My bibliography  Save this article

EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

Author

Listed:
  • Rumona Dickson

    (University of Liverpool)

  • Angela Boland

    (University of Liverpool)

  • Rui Duarte

    (University of Liverpool)

  • Eleanor Kotas

    (University of Liverpool)

  • Nerys Woolacott

    (University of York)

  • Robert Hodgson

    (University of York)

  • Rob Riemsma

    (Kleijnen Systematic Reviews)

  • Sabine Grimm

    (Maastricht University Medical Center)

  • Bram Ramaekers

    (Maastricht University Medical Center)

  • Manuela Joore

    (Maastricht University Medical Center)

  • Nasuh Büyükkaramikli

    (Erasmus University Rotterdam)

  • Eva Kaltenthaler

    (The University of Sheffield)

  • Matt Stevenson

    (The University of Sheffield)

  • Abdullah Pandor

    (The University of Sheffield)

  • Steve Edwards

    (BMJ)

  • Martin Hoyle

    (University of Exeter Medical School)

  • Jonathan Shepherd

    (University of Southampton)

  • Xavier Armoiry

    (University of Warwick)

  • Miriam Brazzelli

    (University of Aberdeen)

Abstract

No abstract is available for this item.

Suggested Citation

  • Rumona Dickson & Angela Boland & Rui Duarte & Eleanor Kotas & Nerys Woolacott & Robert Hodgson & Rob Riemsma & Sabine Grimm & Bram Ramaekers & Manuela Joore & Nasuh Büyükkaramikli & Eva Kaltenthaler &, 2018. "EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties," Applied Health Economics and Health Policy, Springer, vol. 16(4), pages 429-432, August.
    • Handle: RePEc:spr:aphecp:v:16:y:2018:i:4:d:10.1007_s40258-018-0393-7
    DOI: 10.1007/s40258-018-0393-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40258-018-0393-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40258-018-0393-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Paula K Lorgelly, 2018. "The Impact of Brexit on Pharmaceuticals and HTA," PharmacoEconomics - Open, Springer, vol. 2(2), pages 87-91, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sabine E. Grimm & Debra Fayter & Bram L. T. Ramaekers & Svenja Petersohn & Rob Riemsma & Nigel Armstrong & Xavier Pouwels & Willem Witlox & Caro Noake & Gillian Worthy & Jos Kleijnen & Manuela A. Joor, 2019. "Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal," PharmacoEconomics, Springer, vol. 37(10), pages 1195-1207, October.
    2. Iyn-Hyang Lee & Karen Bloor & Eun-Young Bae, 2023. "A Comparative Analysis of Anticancer Drug Appraisals Including Managed Entry Agreements in South Korea and England," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 347-359, March.
    3. Sabine E. Grimm & Nigel Armstrong & Bram L. T. Ramaekers & Xavier Pouwels & Shona Lang & Svenja Petersohn & Rob Riemsma & Gillian Worthy & Lisa Stirk & Janine Ross & Jos Kleijnen & Manuela A. Joore, 2019. "Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal," PharmacoEconomics, Springer, vol. 37(5), pages 655-667, May.
    4. Frederick W. Thielen & Nasuh C. Büyükkaramikli & Rob Riemsma & Debra Fayter & Nigel Armstrong & Ching-Yun Wei & Vanesa Huertas Carrera & Kate Misso & Gill Worthy & Jos Kleijnen & Isaac Corro Ramos, 2019. "Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma," PharmacoEconomics, Springer, vol. 37(8), pages 975-984, August.
    5. Vokinger, Kerstin N. & Muehlematter, Urs Jakob, 2020. "Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018," Health Policy, Elsevier, vol. 124(3), pages 261-267.
    6. Elsa Bouée-Benhamiche & Philippe Jean Bousquet & Salah Ghabri, 2020. "Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 18(4), pages 491-508, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:16:y:2018:i:4:d:10.1007_s40258-018-0393-7. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.